SCHEMBL5135069

SCHEMBL5135069

O=C1N[C@@H]2CCN(C(=O)CBr)C12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FHIT P49789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1687128 1.00 FHIT (0.30) FHIT
SCHEMBL5135067 1.00 FHIT (0.30) FHIT
SCHEMBL5135065 1.00 FHIT (0.30) FHIT
SCHEMBL3668079 0.79 L3MBTL1 (0.33)
SCHEMBL3608557 0.79 L3MBTL1 (0.33)
SCHEMBL2216944 0.70 KDM4E (0.40)
SCHEMBL7195638 0.68 HRH3 (0.51)
SCHEMBL7197551 0.66 ROCK2 (0.38)
SCHEMBL14489745 0.66 DDB1 (0.32)
SCHEMBL1686784 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1965798-A2 USEFUL COMBINATIONS OF MONOBACTAM ANTIBIOTICS WITH BETA-LACTAMASE INHIBITORS Basilea Pharmaceutica AG (CH) 2008-09-10 EP disclosed
WO-2007065288-A2 USEFUL COMBINATIONS OF MONOBACTAM ANTIBIOTICS WITH BETA-LACTAMASE INHIBITORS BASILEA PHARMACEUTICA AG (CH) 2007-06-14 WO disclosed